PATENT CLAIM ANALYSIS

Application Number: 16022323
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "236500"]

Abstract:
Disclosed embodiments concern kinase inhibitors, such as interleukin receptor associated kinases (IRAK) inhibitors, and compositions comprising such inhibitors. Also disclosed are methods of making and using the compounds and compositions. The disclosed compounds and/or compositions may be used to treat or prevent a kinase-associated disease or condition, particularly an IRAK-associated disease or condition.

Claim (Index 14):
The compound of  claim 1 , wherein k is 0.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.38636
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15226625', '15793743', '15136508', '15111000', '15667173']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.790268457349835
- 35 USC 102 Novelty (BERT): 0.5463826405052877
- Combined Prediction Score: 0.7658798756653802
- Mean Citation Score: 363.636908
- Max Citation Score: 396.32117
- Similarity Product: 221.89830402218936

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test